Cambridge Nutritional Science (CNSL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 3.95p
   
  • Change Today:
      0.000p
  • 52 Week High: 4.03
  • 52 Week Low: 1.73
  • Currency: UK Pounds
  • Shares Issued: 237.95m
  • Volume: 127,670
  • Market Cap: £9.40m

ShareCast News

Omega prepares to manufacture Mologic Covid-19 t... 03-Sep-2020 ShareCast
Omega Diagnostics HIV test gets WHO prequalifica... 21-Aug-2020 ShareCast
Omega Diagnostics up on CE-marking of Covid test 30-Jul-2020 ShareCast
Omega Diagnostics completes open offer to raise ... 08-Jul-2020 ShareCast
Omega Diagnostics' ELISA antibody test gets appr... 02-Jul-2020 ShareCast
Omega upbeat on Covid test consortium developments 29-Jun-2020 ShareCast
Omega expands Covid testing work, stops allergy ... 09-Jun-2020 ShareCast
Omega Diagnostics halts development of allergy p... 09-Jun-2020 ShareCast
Omega Diagnostics sees 'significant progress' in... 03-Jun-2020 ShareCast
Omega Diagnostics inks deal with Mologic over Co... 20-Apr-2020 ShareCast
Omega Diagnostics geta approval for HIV test in ... 17-Jan-2020 ShareCast
Omega Diagnostics swings to statutory loss as it... 02-Dec-2019 ShareCast
Omega Diagnostics sees continuing revenue improv... 22-Oct-2019 ShareCast
Omega Diagnostics wins first order for HIV test ... 20-Aug-2019 ShareCast
Omega Diagnostics revenues slip after disposals 17-Apr-2019 ShareCast
Omega Diagnostics CE-marks 'VISITECT CD4' test f... 18-Mar-2019 ShareCast
Omega Diagnostics makes solid progress with 'VIS... 06-Mar-2019 ShareCast
Omega Diagnostics makes good progress with 'VISI... 29-Jan-2019 ShareCast
Omega chairman David Evans steps down after 18 y... 10-Dec-2018 ShareCast
Omega Diagnostics dives as revenue slashed 03-Dec-2018 ShareCast
Omega suffers 'famine' as company swings to pre-... 06-Aug-2018 ShareCast
Novacyt buys Omega Diagnostics' infectious disea... 28-Jun-2018 ShareCast
Omega reaches new milestone with VISITECT CD4 21-May-2018 ShareCast
Omega gets CE-mark on two more allergens 08-May-2018 ShareCast
Omega Diagnostics to close German business as sa... 02-May-2018 ShareCast
Omega Diagnostics inks distribution agreement wi... 20-Apr-2018 ShareCast
Omega Diagnostics signs US supply agreement 16-Oct-2017 ShareCast
Weak sterling pushes Omega Diagnostics revenue h... 25-Apr-2017 ShareCast
IDS looking for wider distribution deal with Ome... 27-Jan-2017 ShareCast
Omega Diagnostics awarded ISO compliance 11-Jan-2017 ShareCast
Omega Diagnostics turnover slightly ahead at the... 17-Oct-2016 ShareCast
Omega Diagnostics secures GBP1.8m R&D grant 02-Aug-2016 ShareCast
Omega Diagnostics increases first half revenue b... 26-Oct-2015 ShareCast
Omega Diagnostics suffers infectious disease tes... 07-Jul-2015 ShareCast
Omega Diagnostics reports good progress in infec... 01-Jun-2015 ShareCast
Omega Diagnostics generates alpha with encouragi... 15-Apr-2015 ShareCast
Omega Diagnostics develops new app for health se... 01-Jul-2014 ShareCast
Omega Diagnostics' full-year results meet targets 23-Jun-2014 ShareCast
Omega Diagnostics makes progress with HIV blood ... 13-Feb-2014 ShareCast
Omega hurt by weak UK, European markets 01-Jul-2013 ShareCast
Omega Diagnostics raises funds for research and ... 24-May-2013 ShareCast
Omega Diagnostics awarded grant for HIV test 19-Nov-2012 ShareCast
Omega Diagnostics unveils strong year 02-Jul-2012 ShareCast
Small caps round-up: Omega Diagnostics, Oxford B... 16-Apr-2012 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CNSL Market Data

Currency UK Pounds
Share Price 3.95p
Change Today 0.000p
% Change 0.00 %
52 Week High 4.03
52 Week Low 1.73
Volume 127,670
Shares Issued 237.95m
Market Cap £9.40m

CNSL Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
78.00% above the market average78.00% above the market average78.00% above the market average78.00% above the market average78.00% above the market average
89.19% above the sector average89.19% above the sector average89.19% above the sector average89.19% above the sector average89.19% above the sector average
Income Not Available
Growth
46.27% below the market average46.27% below the market average46.27% below the market average46.27% below the market average46.27% below the market average
61.11% below the sector average61.11% below the sector average61.11% below the sector average61.11% below the sector average61.11% below the sector average

CNSL Dividends

No dividends found

Trades for 03-May-2024

Time Volume / Share Price
16:21 19,959 @ 3.89p
15:42 20,679 @ 3.89p
15:00 589 @ 3.89p
14:11 901 @ 3.86p
14:03 20,000 @ 3.89p

CNSL Key Personnel

CEO Jag Grewal
Chair Simon Gordon Douglas

Top of Page